Tuesday, June 17, 2014

International Stem Cell Corporation’s (ISCO) VP to Present at BIO 2014

International Stem Cell Corp., a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that Executive Vice President Dr. Simon Craw will present an overview of the company and its subsidiaries at the BIO 2014 conference on Tuesday, June 24th at 4:15 pm PDT. The San Diego Convention Center is hosting the conference in the Mission Beach room. For additional conference details go to: http://convention.bio.org.

Attracting approximately 15,000 of the most influential biotech and pharma participants from over 60 countries, BIO is the largest, most influential biotech meeting in the world. The convention is scheduled to include sessions and specialty forums covering 17 hot topics, over 1,700 exhibitors and BIO One-on-One Partnering™ meetings with thousands of companies from June 23 – 26th. Those interested in attending the conference and/or if you would like to schedule a meeting with ISCO’s management team, please contact the conference organizers. To register for the event visit the conference website at http://convention.bio.org/register.

ISCO’s work is centered on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. Parthenogenesis, the company’s core technology, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs) thereby avoiding ethical issues associated with the use or destruction of viable human embryos. Scientists at the company have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. The offerings of hpSCs possess the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology and stem cell-based skin care products through its subsidiary Lifeline Skin Care.

For more information on the company, visit www.internationalstemcell.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: